ClinVar Miner

Submissions for variant NM_000335.4(SCN5A):c.2677C>T (p.Arg893Cys) (rs199473171)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000619419 SCV000737542 likely pathogenic Cardiovascular phenotype 2016-06-06 criteria provided, single submitter clinical testing
Cardiovascular Biomedical Research Unit,Royal Brompton & Harefield NHS Foundation Trust RCV000058517 SCV000090037 not provided Brugada syndrome no assertion provided literature only This variant has been reported as associated with Brugada syndrome in the following publications (PMID:20129283). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory.
Center for Human Genetics and Laboratory Diagnostics, Dr. Klein, Dr. Rost and Colleagues RCV000678939 SCV000805152 likely pathogenic Brugada syndrome 1 2018-03-09 criteria provided, single submitter clinical testing
GeneDx RCV000183009 SCV000235415 uncertain significance not provided 2016-01-20 criteria provided, single submitter clinical testing The R893C mutation in the SCN5A gene has been reported in two unrelated individuals with Brugada syndrome and was not observed in greater than 1300 healthy control subjects (Kapplinger J et al., 2010). Furthermore, the R893C mutation was not observed inapproximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. R893C results in a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. The R893 residue is highly conserved across species. A mutation in the same residue (R893H) and nearby residues (H886P, I890T, F892I, C896S, E901K) have been reported in association with Brugada syndrome, further supporting the functional importance of this region of the protein. In summary, R893C in the SCN5A gene is interpreted as a disease-causing mutation.
Invitae RCV000058517 SCV000953030 uncertain significance Brugada syndrome 2018-11-09 criteria provided, single submitter clinical testing This sequence change replaces arginine with cysteine at codon 893 of the SCN5A protein (p.Arg893Cys). The arginine residue is highly conserved and there is a large physicochemical difference between arginine and cysteine. This variant is present in population databases (rs199473171, ExAC 0.001%). This variant has been observed in individuals affected with Brugada syndrome (PMID: 28341781, Invitae). ClinVar contains an entry for this variant (Variation ID: 67748). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant disrupts the p.Arg893 amino acid residue in SCN5A. Other variant(s) that disrupt this residue have been observed in affected individuals (PMID: 28341781), which suggests that this may be a clinically significant amino acid residue. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.